Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Results from the Phase 3 DUO TM Trial: A Randomized Comparison of Duvelisib Vs Ofatumumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Blood (2017) 130 (Supplement 1): 493.

https://doi.org/10.1182/blood.V130.Suppl_1.493.493

Published: 2017

Journal Articles

Defining the Malignant Epigenome in Non-Hodgkin Lymphoma

Jacqueline E. Payton, MD, PhD, Olivia I. Koues, PhD, Rodney Kowalewski, BS, Jennifer A. Schmidt, MS, Li-Wei Chang, PhD, Amanda Cashen, MD, Nancy L. Bartlett, MD, Eugene M. Oltz, PhD

Blood (2012) 120 (21): 524.

https://doi.org/10.1182/blood.V120.21.524.524

Published: 2012

Journal Articles

A Phase 2 Multicenter Study of Continuous Dose Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Todd A. Fehniger, MD/PhD, Sarah Larson, Kathryn Trinkaus, PhD, Marilyn J. Siegel, MD, David D. Hurd, MD, Kristie A. Blum, MD, Andre Goy, MD, Timothy S. Fenske, MD, Amanda Cashen, MD, Nina D. Wagner-Johnston, MD, Kenneth R. Carson, MD, Nancy L. Bartlett, MD

Blood (2012) 120 (21): 1623.

https://doi.org/10.1182/blood.V120.21.1623.1623

Published: 2012

Journal Articles

Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older with Acute Myeloid Leukemia,

Meagan A Jacoby, MD/PhD, Michael Martin, Teresa Reineck, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD, Amanda Cashen, MD, Keith Stockerl-Goldstein, MD, Geoffrey L. Uy, MD, Ravi Vij, MD, Camille N. Abboud, MD

Blood (2011) 118 (21): 3633.

https://doi.org/10.1182/blood.V118.21.3633.3633

Published: 2011

Journal Articles

Phase I Study of Cladribine (2-chlorodeoxyadenosie), Cytarabine and G-CSF Based Induction Therapy (CLAG) with ATRA (All-trans retinoic acid) and Midostaurin for Relapsed/Refractory AML,

Giridharan Ramsingh, MD, Andrew Sprau, M.S, Peter Westervelt, MD, PhD, Ali McBride, PharmD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MD, Geoffrey L. Uy, MD, Amanda Cashen, MD, John F. DiPersio, MD, PhD, Camille N. Abboud, MD

Blood (2011) 118 (21): 3609.

https://doi.org/10.1182/blood.V118.21.3609.3609

Published: 2011

Journal Articles

A Phase 1 Study of Concomitant High Dose Lenalidomide and 5-Azacytidine Induction in the Treatment of Acute Myeloid Leukemia,

Giridharan Ramsingh, MD, Peter Westervelt, MD, PhD, Amanda Cashen, MD, Geoffrey L. Uy, MD, Keith Stockerl-Goldstein, MD, Camille N. Abboud, MD, Ryan Monahan, BA, CCRP, John F. DiPersio, MD, PhD, Ravi Vij, MD

Blood (2011) 118 (21): 3616.

https://doi.org/10.1182/blood.V118.21.3616.3616

Published: 2011

Journal Articles

Outcomes In Allogeneic Hematopoietic Stem Cell Transplantation for Peripheral T-Cell Lymphoma: A Single Center's 12-Year Experience

Hans C Lee, MD, Keith E. Stockerl-Goldstein, MD, Qin Zhang, MS, Amanda Cashen, MD

Blood (2010) 116 (21): 2360.

https://doi.org/10.1182/blood.V116.21.2360.2360

Published: 2010

Journal Articles

Decitabine for Older AML Patients: An Effective Therapy Associated with Short Hospitalization and No Invasive Fungal Infection.

George Ansstas, MD, Waseem Touma, MD, Camille Adeimy, MD, Gao Feng, Peter Westervelt, MD, PhD, Camille N. Abboud, MD, Geoffrey L. Uy, MD, Keith E. Stockerl-Goldstein, MD, Amanda Cashen, MD, John F. DiPersio, MD, PhD, Ravi Vij, MBBS, MD

Blood (2010) 116 (21): 1063.

https://doi.org/10.1182/blood.V116.21.1063.1063

Published: 2010

Journal Articles

Phase I Study of Intravenous Plerixafor Added to a Mobilization Regimen of G-CSF In Lymphoma Patients Undergoing Autologous Stem Cell Collection

Amanda Cashen, MD, Michael P. Rettig, PhD, Feng Gao, PhD, Camille N. Abboud, MD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD

Blood (2010) 116 (21): 823.

https://doi.org/10.1182/blood.V116.21.823.823

Published: 2010

Journal Articles

A Retrospective Review of Response to Donor Leukocyte Infusions In Adults with Acute Myeloid Leukemia After Reduced Intensity Conditioned Allogeneic Hematopoietic Cell Transplantation.

Loretta Nastoupil, MD, Mark A. Schroeder, MD, Qin Zhang, MS, Uy Geoffrey, MD, Amanda Cashen, MD, Keith E. Stockerl-Goldstein, MD, Camille N. Abboud, MD, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD, Ravi Vij, MBBS, MD

Blood (2010) 116 (21): 4512.

https://doi.org/10.1182/blood.V116.21.4512.4512

Published: 2010

Journal Articles

A Phase II Study of Intravenous Azacitidine Alone in Patients with Myelodysplastic Syndromes NCT00384956.

Richard Walgren, MD, PhD, Crystal Dao, MA, Frederieke Kreisel, MD, Peter Westervelt, MD, PhD, Camille Abboud, MD, Timothy Graubert, MD, Amanda Cashen, MD, Geoffrey Uy, MD, Feng Gao, MD, John DiPersio, MD, PhD, Ravi Vij, MD

Blood (2007) 110 (11): 1451.

https://doi.org/10.1182/blood.V110.11.1451.1451

Published: 2007

Journal Articles

Phase II Study of Low-Dose Decitabine for the Front-Line Treatment of Older Patients with Acute Myeloid Leukemia (AML).

Amanda Cashen, MD, Gary J. Schiller, MD, Julie S. Larsen, PharmD, Michael T. Cullen, Jr., MD, John F. DiPersio, MD, PhD

Blood (2006) 108 (11): 1984.

https://doi.org/10.1182/blood.V108.11.1984.1984

Published: 2006

Journal Articles

AMD3100 + G-CSF Improves Hematopoietic Progenitor Cell (HPC) Collection in Patients with Hodgkin’s Disease (HD).

Amanda Cashen, MD, Steven Devine, MD, Ravi Vij, MD, John DiPersio, MD

Blood (2005) 106 (11): 1979.

https://doi.org/10.1182/blood.V106.11.1979.1979

Published: 2005

Journal Articles

A Phase I Pharmacokinetic Trial of Decitabine Administered as a 3-Hour Infusion to Patients with Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS).

Amanda Cashen, MD, Ajit Shah, PhD, Angela Helget, Laura Todt, Nicholas Fisher, John DiPersio, MD, PhD

Blood (2005) 106 (11): 1854.

https://doi.org/10.1182/blood.V106.11.1854.1854

Published: 2005

NARROW

Results from the Phase 3 DUO TM Trial: A Randomized Comparison of Duvelisib Vs Ofatumumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Defining the Malignant Epigenome in Non-Hodgkin Lymphoma

A Phase 2 Multicenter Study of Continuous Dose Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older with Acute Myeloid Leukemia,

Phase I Study of Cladribine (2-chlorodeoxyadenosie), Cytarabine and G-CSF Based Induction Therapy (CLAG) with ATRA (All-trans retinoic acid) and Midostaurin for Relapsed/Refractory AML,

A Phase 1 Study of Concomitant High Dose Lenalidomide and 5-Azacytidine Induction in the Treatment of Acute Myeloid Leukemia,

Outcomes In Allogeneic Hematopoietic Stem Cell Transplantation for Peripheral T-Cell Lymphoma: A Single Center's 12-Year Experience

Decitabine for Older AML Patients: An Effective Therapy Associated with Short Hospitalization and No Invasive Fungal Infection.

Phase I Study of Intravenous Plerixafor Added to a Mobilization Regimen of G-CSF In Lymphoma Patients Undergoing Autologous Stem Cell Collection

A Retrospective Review of Response to Donor Leukocyte Infusions In Adults with Acute Myeloid Leukemia After Reduced Intensity Conditioned Allogeneic Hematopoietic Cell Transplantation.

A Phase II Study of Intravenous Azacitidine Alone in Patients with Myelodysplastic Syndromes NCT00384956.

Phase II Study of Low-Dose Decitabine for the Front-Line Treatment of Older Patients with Acute Myeloid Leukemia (AML).

AMD3100 + G-CSF Improves Hematopoietic Progenitor Cell (HPC) Collection in Patients with Hodgkin’s Disease (HD).

A Phase I Pharmacokinetic Trial of Decitabine Administered as a 3-Hour Infusion to Patients with Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only